Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Afatinib industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Beacon Pharma
Boehringer Ingelheim
Hengrui Medicine
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
30mg Tables
40mg Tables
50mg Tables
25mg Tables
20mg Tables
Other
Application:
Hospital
Clinic
Drug Center
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Afatinib Industry Overview
-
1.1.1 Afatinib Market Scope and Market Segments
-
1.1.2 Afatinib Industry Characteristics
-
1.1.3 Global and China Afatinib Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Afatinib Production Value and Growth Rate (2017-2028)
-
1.2 Global Afatinib Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 30mg Tables
-
1.2.2 40mg Tables
-
1.2.3 50mg Tables
-
1.2.4 25mg Tables
-
1.2.5 20mg Tables
-
1.2.6 Other
-
1.3 Global Afatinib Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Clinic
-
1.3.3 Drug Center
-
1.3.4 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Afatinib Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Afatinib Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Afatinib Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Afatinib Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Afatinib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Afatinib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Afatinib Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Afatinib Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Afatinib Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Afatinib Industry Porter's Five Forces Model Analysis
-
2.2.3 Afatinib Industry PEST Analysis
-
2.3 Afatinib Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Afatinib Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Afatinib Industry
Chapter 3 Global and China Afatinib Market, by Manufacturer
-
3.1 Global and China Afatinib Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Afatinib Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Afatinib Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Afatinib Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Afatinib Market Top 3 Players
Chapter 4 Global and China Afatinib Market, by Type (2017-2028)
-
4.1 Afatinib Market Trend, by Type
-
4.2 Global Afatinib Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Afatinib Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Afatinib Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Afatinib Price Trend, by Type (2017-2028)
-
4.3 China Afatinib Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Afatinib Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Afatinib Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Afatinib Price Trend, by Type (2017-2028)
Chapter 5 Global and China Afatinib Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Afatinib Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Afatinib Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Afatinib Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Afatinib Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Afatinib Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Afatinib Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Afatinib Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Afatinib Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Afatinib Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Afatinib Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Afatinib Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Afatinib Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Afatinib Market Analysis
-
7.1 North America Afatinib Market, by Type
-
7.2 North America Afatinib Market, by Application
-
7.3 North America Afatinib Market Analysis and Forecast, by Country
-
7.3.1 United States Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Afatinib Market Analysis
-
8.1 Europe Afatinib Market, by Type
-
8.2 Europe Afatinib Market, by Application
-
8.3 Europe Afatinib Market Analysis and Forecast, by Country
-
8.3.1 Germany Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Afatinib Market Analysis
-
9.1 APAC Afatinib Market, by Type
-
9.2 APAC Afatinib Market, by Application
-
9.3 APAC Afatinib Market Analysis and Forecast, by Country
-
9.3.1 China Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Afatinib Market Analysis
-
10.1 Latin America, Middle East and Africa Afatinib Market, by Type
-
10.2 Latin America, Middle East and Africa Afatinib Market, by Application
-
10.3 Latin America, Middle East and Africa Afatinib Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Afatinib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Afatinib Company Profiles
-
11.1 Beacon Pharma
-
11.1.1 Beacon Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Beacon Pharma Afatinib Product Profiles, Application and Specification
-
11.1.3 Beacon Pharma Afatinib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Boehringer Ingelheim
-
11.2.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Boehringer Ingelheim Afatinib Product Profiles, Application and Specification
-
11.2.3 Boehringer Ingelheim Afatinib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Hengrui Medicine
-
11.3.1 Hengrui Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Hengrui Medicine Afatinib Product Profiles, Application and Specification
-
11.3.3 Hengrui Medicine Afatinib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Afatinib Industry Investment Prospect and Risk Assessment
-
12.1 Afatinib Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Afatinib Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure China Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Global Afatinib Production Value and Growth Rate (2017-2028)
-
Figure China Afatinib Production Value and Growth Rate (2017-2028)
-
Figure Global Afatinib Market Size and Growth Rate of 30mg Tables (2017-2028)
-
Figure Global Afatinib Market Size and Growth Rate of 40mg Tables (2017-2028)
-
Figure Global Afatinib Market Size and Growth Rate of 50mg Tables (2017-2028)
-
Figure Global Afatinib Market Size and Growth Rate of 25mg Tables (2017-2028)
-
Figure Global Afatinib Market Size and Growth Rate of 20mg Tables (2017-2028)
-
Figure Global Afatinib Market Size and Growth Rate of Other (2017-2028)
-
Figure Global Afatinib Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Afatinib Market Size and Growth Rate of Clinic (2017-2028)
-
Figure Global Afatinib Market Size and Growth Rate of Drug Center (2017-2028)
-
Figure Global Afatinib Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Afatinib Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Afatinib Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Afatinib Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Afatinib Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Afatinib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Afatinib Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Afatinib Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Afatinib Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Afatinib Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Afatinib Market Share, by Manufacturer in 2021
-
Figure Global and China Afatinib Market Share, by Manufacturer in 2022
-
Table Global Afatinib Sales Volume, by Type (2017-2028)
-
Table Global Afatinib Sales Volume Share, by Type (2017-2028)
-
Figure Global Afatinib Sales Volume Share, by Type (2017-2028)
-
Table Global Afatinib Sales Value, by Type (2017-2028)
-
Table Global Afatinib Sales Value Share, by Type (2017-2028)
-
Figure Global Afatinib Price Trend, by Type (2017-2028)
-
Table China Afatinib Sales Volume, by Type (2017-2028)
-
Table China Afatinib Sales Volume Share, by Type (2017-2028)
-
Figure China Afatinib Sales Volume Share, by Type (2017-2028)
-
Table China Afatinib Sales Value, by Type (2017-2028)
-
Table China Afatinib Sales Value Share, by Type (2017-2028)
-
Figure China Afatinib Price Trend, by Type (2017-2028)
-
Table Global Afatinib Sales Volume, by Application (2017-2028)
-
Table Global Afatinib Sales Volume Share, by Application (2017-2028)
-
Figure Global Afatinib Sales Volume Share, by Application (2017-2028)
-
Table Global Afatinib Sales Value, by Application (2017-2028)
-
Table Global Afatinib Sales Value Share, by Application (2017-2028)
-
Figure Global Afatinib Sales Value Share, by Application (2017-2028)
-
Table China Afatinib Sales Volume, by Application (2017-2028)
-
Table China Afatinib Sales Volume Share, by Application (2017-2028)
-
Figure China Afatinib Sales Volume Share, by Application (2017-2028)
-
Table China Afatinib Sales Value, by Application (2017-2028)
-
Table China Afatinib Sales Value Share, by Application (2017-2028)
-
Figure China Afatinib Sales Value Share, by Application (2017-2028)
-
Figure China Afatinib Production, Import, Consumption and Export (2017-2022)
-
Figure North America Afatinib Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Afatinib Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Afatinib Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Afatinib Production, Import, Consumption and Export (2017-2022)
-
Table North America Afatinib Sales Volume, by Type (2017-2028)
-
Table North America Afatinib Sales Volume Share, by Type (2017-2028)
-
Figure North America Afatinib Sales Volume Share, by Type (2017-2028)
-
Table North America Afatinib Sales Volume, by Application (2017-2028)
-
Table North America Afatinib Sales Volume Share, by Application (2017-2028)
-
Figure North America Afatinib Sales Volume Share, by Application (2017-2028)
-
Figure United States Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure United States Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure Canada Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Afatinib Sales Value and Growth Rate (2017-2028)
-
Table Europe Afatinib Sales Volume, by Type (2017-2028)
-
Table Europe Afatinib Sales Volume Share, by Type (2017-2028)
-
Figure Europe Afatinib Sales Volume Share, by Type (2017-2028)
-
Table Europe Afatinib Sales Volume, by Application (2017-2028)
-
Table Europe Afatinib Sales Volume Share, by Application (2017-2028)
-
Figure Europe Afatinib Sales Volume Share, by Application (2017-2028)
-
Figure Germany Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure UK Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure UK Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure France Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure France Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure Italy Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure Spain Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure Poland Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure Russia Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Afatinib Sales Value and Growth Rate (2017-2028)
-
Table APAC Afatinib Sales Volume, by Type (2017-2028)
-
Table APAC Afatinib Sales Volume Share, by Type (2017-2028)
-
Figure APAC Afatinib Sales Volume Share, by Type (2017-2028)
-
Table APAC Afatinib Sales Volume, by Application (2017-2028)
-
Table APAC Afatinib Sales Volume Share, by Application (2017-2028)
-
Figure APAC Afatinib Sales Volume Share, by Application (2017-2028)
-
Figure China Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure China Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure Japan Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure India Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure India Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Afatinib Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Afatinib Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Afatinib Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Afatinib Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Afatinib Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Afatinib Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Afatinib Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Afatinib Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Afatinib Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Afatinib Sales Value and Growth Rate (2017-2028)
-
Table Beacon Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Beacon Pharma Product Profiles, Application and Specification
-
Table Beacon Pharma Afatinib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Boehringer Ingelheim Product Profiles, Application and Specification
-
Table Boehringer Ingelheim Afatinib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Hengrui Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Hengrui Medicine Product Profiles, Application and Specification
-
Table Hengrui Medicine Afatinib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
